Proskauer Rose LLP

Proskauer Rose LLP advises on IP litigations, prosecution, and transactions, with a focus on biotech, pharma, and medical device clients. The firm is also active in FDA regulatory and product liability litigation matters. The practice is led by Boston-based Fangli Chen, who specializes in litigation, strategic IP portfolio development, and IP matters in connection with commercial transactions, along with New York’s Daryn Grossman, who focuses on tech and IP transactions, including strategic alliances. The team saw significant expansion in 2024, welcoming litigator Craig Whitney from Frankfurt Kurnit Klein & Selz PC in New York and antitrust litigator Mark Rosman from Wilson Sonsini Goodrich & Rosati in Washington DC. Joining the DC and New York teams from Hughes Hubbard & Reed LLP, Kevin Abikoff is experienced in securities and white-collar criminal litigation, investigations, enforcement, regulation, and counseling.